This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

AN EXPERIMENTAL STUDY

HAROLD B. MYERS, M.D.; LOUIS GOODMAN, B.A.

Arch Intern Med. 1932;49(6):946-949.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Numerous reports in the recent medical literature refer to evidences of severe liver damage, not infrequently resulting in death, in patients given cinchophen as the chief or sole therapeutic agent. This drug, originally introduced in 1908 as a mobilizer of uric acid and advocated for the relief of gout, has come to be commonly utilized as an analgesic, particularly for the relief of pain of rheumatic type. The more common use of this drug makes a further understanding of its toxic action highly desirable.

A few references were made to toxic reactions, such as the tendency to cause urticaria or digestive disturbances,¹ early in the use of this drug, but the possibility of serious consequences was not appreciated until recently. Cabot,² in 1925, first reported a death with acute hepatic atrophy following the use of cinchophen. A report on "The Specific Character of Toxic Cirrhosis as Observed in . . . [Full Text PDF of this Article]

Author Affiliations
PORTLAND, ORE.

From the Laboratory of Pharmacology, University of Oregon Medical School.

Footnotes
Submitted for publication, Sept. 25, 1931.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?